Bloodborne HIV: Don't Get Stuck!

Protect yourself from bloodborne HIV during healthcare and cosmetic services

Tag Archives: hepatitis

Will Pathfinder’s Ethiopian Implanon Implant Project Be Safe?


Pathfinder International are intending to scale up the use of Implanon in Ethiopia. This is a hormonal contraceptive implant, inserted under the skin. I hope some care is taken to avoid accidental transmission of blood borne infections, such as hepatitis, HIV and various bactrial conditions.

My attention has been drawn to the 2005 Demographic and Health Survey for Ethiopia, which shows that HIV prevalence is particularly high among women who received care from a health professional during delivery in the past three years, at 9.9%, compared to national prevalence of less than 1.5%. In contrast, HIV prevalence among those who gave birth without care from a health professional was only 1.2%.

There are similarly worrying contrasts for ante-natal care (ANC), with 3.5% prevalence among those who receive ANC by a health professional, compared to only 1% among those who did not.

In common with all high HIV prevalence African countries, HIV prevalence is higher among women than men. It is also many times higher in urban areas, compared to rural areas. And it is higher among the wealthy than it is among the poor.

These figures, and others in a more recent Preliminary Demographic and Health Survey for Ethiopia, suggest that HIV is very unlikely to be transmitted sexually. This raises the question of how it is being transmitted. Could wealthier, city dwelling people, with better access to health professionals face higher risks than poorer, rural dwelling people, who may never see a health professional face to face? Contraceptive use is also far higher in urban than rural areas.

Pathfinder use the popular buzzword, ‘task-shifting’, to reassure us that there may be few health professionals in the country, but some kind of training can be given to those there are, even to those who are not health professionals but are doing work that should be done by professionals. The term ‘task-shifting’ is a bit like ‘coping mechanisms’ and ‘extended families’, which allow us to believe that they’ll be ok, after all, they are Africans.

It is to be hoped that use of Implanon and other invasive family planning methods that involve breaking of the skin are carried out in sterile conditions by people who know the risks and are taking the necessary precautions to avoid them.

It would also be good to think this campaign involves informing Ethiopians about non-sexual risks of HIV transmission, such as those faced by those using certain forms of birth control, such as Implanon and other implants. Implants need to be removed in sterile conditions, as well as inserted in sterile conditions.

Western Researchers in Africa Leave Their Principles at Home


The Rebecca Project has published a policy brief on non-consensual research in African countries, invoking the US town of Tuskegee in the title, where non-consensual research into syphilis saw many African Americans being infected with the disease and passing it on to their children and partners as a known (to the researchers) consequence of the program. Similar work was carried out in Guatemala, for which the US government has recently ‘apologised’.

Much of the research currently being carried out in African countries by US companies and US funded institutions is unethical and illegal. It results in innocent people being infected with diseases and affected by side-effects in ways that would be entirely unacceptable in Western countries, even in the US. Often, the people abused by these researchers are led to believe they are receiving routine medical care.

Sometimes informed consent is sought; sometimes it is given. But there is always a question mark over how well informed people can be when they may only have primary education or less, and education of very low quality, at that. It is in the interest of those recruiting participants to supply the numbers required, so the less participants know, the better for the researchers.

The Rebecca Project wishes to see these practices investigated and discussed at congressional hearings. They hope that this will lead to reforms in the institutions involved so that such abuses no longer occur, the protection of victims and the punishment of the perpetrators for these crimes against humanity.

David Gisselquist of Don’t Get Stuck With HIV has also written a comprehensive review of the literature showing massive levels of such unethical and illegal research, involving many tens of thousands of Africans. It would be impossible now to reverse the damage that has been done, for various reasons, including lack of care taken to record and report vital information on the victims. (A copy of Gisselquist’s review can be downloaded from the DGS site.) But these practices must stop.

Both the Rebecca Project brief and Gisselquist’s review bring home the fact that there are many people involved in carrying out these activities, scientists, policy experts, politicians and medical personnel, from rich countries as well as from developing countries. Many of the people involved are among the best informed and best educated in the business. If their education in ethical behavior is as seriously lacking as it appears to be, they should not have been involved in the first place.

If experiments on children, intentional or avoidable infection with an incurable and deadly disease, failure to obtain consent or to provide information that could influence consent and other excesses brought to light in these documents involved Jews, Romani people , homosexuals or other groups, instead of Africans, would they have been allowed to take place? And if they took place, would they be allowed to continue, as they are being allowed to in African countries right now?

Rebecca Project documents abuses that took place in a number of countries, as recently as the last few years, carried out by pharmaceutical multinationals, US health institutions, high profile donors such as the Gates and Rockefeller Foundations, international NGOs such as FHI and others. Often present is the notion of ‘population control’, something that is never far from the ideology of the various US parties involved. Reducing population is considered by many of these parties to be a viable development paradigm, although a lot of development theorists might classify it as being of mere historical interest.

Some of the incidents involved the use of the injectible hormonal contrecptive Depo Provera, mentioned on this blog on several occasions. Participants were told they were receiving routine health care. Another involved the use of the HIV drug Tenofovir, which has had quite a short but highly chequered history. They were not informed about the risks involved. Both drugs are still widely used, though questions have long been raised about many of their uses.

The list goes on, some of the drugs and pharmaecutical companies being well known, others not so well promoted in the mainstream press. To be fair, some of those who profited from the work, or who could have done so, raised objections. But they were mostly ignored until a lot of damage had been done. A few million in bribes and a few hundred thousand in ‘compensation’ is nothing to the multi-billion dollar pharmaceutical industry. They have survived many such crises and are likely to survive many more, unlike their victims. For the industry, being forced to address a fraction of the damage they do is only a very small cost, but the profits are massive.

The list of abuses is disgusting, including sterilization of women after getting consent through intimidation, pressure or cash, failing to report deaths and serious injuries and using babies and pregnant women as human subjects. One researcher reported being “unfairly assailed by pedantic saboteurs who could not grasp the necessary difference between U.S. safety standards and the more lenient standards that a country like Uganda deserved.”

Media attention can be way out of proportion when it comes to certain issues, such as some questionable findings about HIV medications or the ‘lack of evidence’ of any danger with using Depo Provera. But these kinds of systematic abuses by academics, political and industrial leaders and other powerful people which the Rebecca Project outline just seem to pass unnoticed by the proponents of ‘public interest’. Perhaps here, public interest is outweighed by financial interest? Or maybe the powerful are ‘us’ and Africans are just ‘them’, when it comes to the mainstream press?

There’s more. But I think the point is clear: there are many double standards involved in research, where all sorts of inhuman procedures can be carried out in African countries but not in the West. And abuses that take place in African countries are systematically covered up, if records are even available to conceal, lies are told, whistleblowers are discredited and public money goes into whatever supports the status quo, and shies away from anything remotely like change for the better.

Population Control Theory of Development is Fallacious and Dangerous


Westerners’ obsession with population control in developing countries at all costs can be hard to fathom. Tens of millions of aid dollars are spent on Depo Provera and similar hormonal contraceptives, alone, which have long been known to be unsafe. Needless to say, they are mainly used by people in poor countries, especially in African countries.

But the dangers of Depo Provera, which includes HIV transmission from men to women and from women to men, are considered a small price to pay for the satisfaction of the Western mind, which is convinced that if there were fewer people in poor countries, the ones left wouldn’t be so poor; and that the way to achieve this panacea is to push contraceptives of all kinds, safe, unsafe, expensive, cheap, effective and ineffective, on poor people.

So the Reproductive Health Reality Check site argues for the benefits of the copper intrauterine device (IUD), without reference to the wishes of those who may be recipients of Western funded IUD programs. Without reference also to the safety of widespread use of these devices.

What about countries with less than half the health personnel they need, less than half the hospitals and medical supplies? Where many people never see a trained health professional and where many of those who do are more likely to be infected with something incurable at the clinic than in their own homes?

Some become so fervent about population control that they implement female sterilization programs, advocate for them or try to foist them on women, who are promised a great life as a result. Sometimes they are bribed or otherwise coerced into accepting something that is not what they want and may do a lot of harm, medically and socially.

While this may sometimes elicit some sympathy even from those who still think enforced population control is acceptable and effective, they don’t seem so worried about the risks of nosocomial infection with HIV, hepatitis and other diseases that women face when they go to a health facility.

The whole population control theory of development is on shaky ground, anyhow. True, there are many people whose families are too big. But lower birth rates follow developments in health, education and social services, not the other way around. Small families in Tanzania and other African countries are usually from wealthier and better educated families themselves; the family doesn’t become wealthy just because there are few children.

Clinton’s HIV-Free Generation Delusion


Clinton got a lot of attention by claiming that an AIDS-free generation is now possible. She claims this on the basis of fairly flimsy reasoning. Firstly, the best way of preventing mother to child HIV transmission is to ensure that mothers do not get infected. Blindingly obvious as that may sound, until that is made a priority, there will be no AIDS-free generation.

The facts that HIV can be transmitted sexually and that pregnant women have almost certainly been engaging in unprotected sex does not mean that HIV positive pregnant women, and those who have recently given birth, were necessarily infected sexually. If their sexual partner was also tested, it would be found that many of them are HIV negative. But partners are not routinely tested.

Instead, it is assumed that if a woman is infected with HIV, either her partner infected her or she has other partners, one of whom infected her. The fact that she insists otherwise is not generally taken into consideration. It is implied that African women, the biggest HIV positive group in the world by a long shot, generally lie.

Clinton also grabs at mass male circumcision, another highly questionable HIV prevention intervention. Even some HIV politbureau approved sources have shown that the evidence is not conclusive, that while in a number of countries HIV prevalence appears to be higher among uncircumcised men, in others prevalence is lower. In addition, while male circumcision is said to reduce transmission from females to males, it has also been suggested that it increases transmission from males to females.

The third intervention Clinton mentions, because these things so often come in threes, is scaling up treatment for people living with HIV. She may remember the ‘three by five’ initiative, the aim to get three million people on antiretroviral treatment (ART) by the year 2005? It took longer than expected. And six years later, the figure is still a long way from being doubled, at about five million.

One of the reasons why less than one third of the estimated 15 million people in need of ART receive it is because they are so incredibly expensive. Clinton makes a big thing of mentioning her husband’s foundation, which has orchestrated very well publicized ‘reductions’ in drug prices. But those reductions were from levels unaffordable anywhere to levels unaffordable in the countries where the majority of HIV positive people live.

In fact, countries with high HIV prevalence are not even able to guarantee an adequate supply of drugs to those on treatment, often only 20-25% of those in need. Many countries regularly run out of testing kits and other supplies. And as for anything beyond pharmaceuticals, because they are a profitable business, forget it. People without enough food or clean water are often more likely to to get HIV drugs than any other form of treatment. So they die of all sorts of things, just not headline diseases.

Combining these interventions, even by including many others, will have little impact on the worst epidemics until non-sexual drivers of the virus have been identified, investigated and eliminated. But Clinton made no mention of things like unsafe healthcare or cosmetic services. And why would she? Mention of such matters is not politbureau approved.

Far from ushering in a HIV-free generation, the big players in the HIV industry have been keeping things ticking over nicely for years, and reaping ever-increasing profits. Given Clinton’s remarks (and her husband’s machinations), this is likely to continue for the foreseeable.

UNAIDS Feels That Africans Don’t Have a Clue About HIV/AIDS


An interesting article appeared a few years ago in the African Journal of Political Science and International Relations about the African Diaspora, global learning and HIV/AIDS. The authors, Ngoyi K. Zacharie Bukonda and Tumba Ghislain Disashi, members of the African Diaspora themselves, are troubled by a number of things, not least the fact that they are not even given credit for their humanitarian work in Africa by Africans, let alone by non-Africans.

They carried out a program aiming to reduce HIV infection through unsafe medical practices in healthcare facilities in the Democratic Republic of Congo. They ran hundreds of training courses in infection control procedures and related issues, covering reduction of transmission of HIV, hepatitis and other blood borne diseases, quality improvement, and the like.

The authors note the patronizing attitude of non-Africans towards Africans in the HIV/AIDS field, where the dominant paradigm is of heterosexual transmission of the virus, with non-sexual transmission, such as through unsafe healthcare practices, almost entirely dismissed. This paradigm is even accepted and taught throughout African healthcare systems, despite substantial bodies of evidence that unsafe healthcare probably makes a significant contribution.

The paradigm is so pervasive that Africans, at home and abroad, view HIV/AIDS as a disease that results from promiscuous behavior, one that infects promiscuous people. The authors have not come across any other HIV/AIDS programs initiated by members of the African Diaspora that address this vital area of non-sexual (or vertical) HIV transmission.

A broader view of global learning is suggested on the basis of the authors’ experience of engaging their fellow Africans in this program, where things can be less formal and less geared towards specific qualifications. They feel that the part global learning could play in things like poverty reduction and HIV prevention and treatment have been neglected in standard definitions of the concept.

In addition, Africans of the Diaspora have not been accepted by the broader academic community as learners or as facilitators of global learning. They are not considered to have the capability or the inclination to mitigate epidemics such as HIV/AIDS, nor any other global problem, such as poverty. They do not even get recognition from Africans for what they have achieved and are depicted as disloyal and unpatriotic in the African press.

It is very disturbing that the view of the HIV industry towards Africans is not just that HIV is a disease spread by their own behavior, but also that Africans, even well educated Africans, are not capable of analysing HIV epidemics and allocating appropriate resources on the basis of differing circumstances that prevail among different African countries and within different parts of those countries.

Upholding HIV Orthodoxy Far More Important Than African Lives


United Press International’s health section has an article about the possibility that salons providing manicures, pedicures, shaving and other services may not be taking adequate precautions to avoid transmitting hepatitis to their clients. The report finds that “barbershop nail files, brushes, finger bowls, foot basins, buffers, razors, clippers and scissors may transmit hepatitis”. That’s no surprise here on the Don’t Get Stuck blog, but it’s not often you’ll find it mentioned in a health department report.

Hepatitis B or C may be transmitted through these reusable instruments unless they are properly cleaned and disinfected. A commentator concludes that “The risk of transmission of infectious disease, particularly hepatitis B and C, in personal care settings is significantly understudied in the United States [my emphasis].”

That’s all very well for the US and other Western countries, where disinfection procedures are more widely known and there are enforceable regulations in place. But in resource poor countries, such as Tanzania, Kenya and Uganda, manicures, pedicures and other cosmetic procedures often take place in the open air, in shops, homes and offices, and they are carried out by people with little or no training.

Not only are these risks not studied but they are considered to be negligible by those tasked with reducing transmission of HIV and other blood borne viruses. In the absence of any investigation whatsoever, it is concluded that almost all HIV transmission in African countries results from ‘unsafe’ heterosexual behavior. In addition to being incorrect, this is highly stigmatizing.

Risks faced in health facilities are also denied by UNAIDS, WHO and the like.  There’s an article on HealthLeaders Media site about cancer patients in a Nebraska, US clinic who are infected with hepatitis C because a nurse changed a needle when moving on to another patient, but reused the syringe. Some healthcare professionals seem to think that carries no risk of transmission, but they are wrong. Almost 100 patients were found to be infected after a thorough investigation, involving the recall of thousands of patients.

Despite the investigation, CDC (US Centers for Disease Control and Prevention) say this and other similar incidents are just the tip of the iceberg; the entire might of the US public health sector doesn’t appear to know the full extent of the problem. Instances of reused syringes, reused saline bags and other devices were recorded. But outside of these investigations, most of those infected by such incidents tend to be discovered by accident.

The risk of infection with hepatitis, HIV and other blood borne viruses from healthcare and cosmetic services may seem small, but it’s still a risk, especially in countries where prevalence of blood borne diseases is very high. There is no excuse for assuming that a very small percentage of these services are likely to transmit diseases and that, therefore, the majority of HIV infections are from unsafe sex.

People availing of the services and people providing the services need to be aware of the risks and what steps they take to can avoid them. Healthcare and cosmetic service transmission of blood borne diseases in African countries is in urgent need of investigation.

Tanzanian Hospitals Experience Regular Shortages of Medicines and Medical Supplies


A Tanzanian organization called Sikika (meaning noticeable or audible) has surveyed 30 health facilities and 71 districts (just over half of all districts) to assess the availability of medicines and medical supplies, concentrating on absorbant gauze, but also looking at supplies of surgical gloves, syringes, ALU (Artemether/Lumefantrine, for treating malaria), quinine injections and amoxicillin. The findings are very disturbing. Up to 50% or more of the facilities lacked supplies of at least one of the surveyed items. Up to 50% or more had no gauze, 40% had less than they needed and only 8% had sufficient supplies. Shortages could last for up to six months.

This can be compared to the work that Marc Koska did to demonstrate to health officials in Tanzania that there was a need to look at the role of injecting equipment reuse in transmitting HIV and other blood borne viruses, reviewed yesterday. These shortages are extremely unlikely to be confined to the five surveyed items, either. Representatives of the Ministry of Health and Social Welfare and of the Medical Stores Department did not respond to the survey.

The researchers do not appear to have asked what health professionals do when they have run out of such supplies. Do they treat fewer people, do they reuse supplies, with or without an attempt to sterilize them? Myself and a colleague have asked people working in healthcare that question; they appeared to think it obvious that they would reuse supplies. The report lists various contingency measures, such as borrowing from neighbouring hospitals, asking patients to supply, sending patients to other facilities, etc. But if most hospitals don’t have enough supplies these measures must be limited in effect. Some cancelled elective surgeries and others suggested that the numbers of cross infections and complications would increase as a result of shortages.

The study aimed to survey the extent of the problem, find out what was being done about it and how patients were affected by it. They also interviewed health officials from Uganda and Kenya to compare the three countries. Some of the shortages were due to lack of funds available to individual facilities. Orders were placed for lower levels of supplies than required and surgery had to be cancelled for all but emergency cases. But the entire procurement and distribution process was found to be in urgent need of revision.

The study also highlights a massive shortage of public pharmacies, even in areas which are not particularly isolated, such as Dodoma, the administrative capital of Tanania. There are only about 700 trained pharmacists in the whole country, which has a population of over 40 million, and pharmacies are concentrated in cities and big towns. Over 75% of tanzanians live in rural areas. Medicines and medical supplies are all procured through the Medical Stores Department, a centralized agency, and they are currently reforming their delivery system.

Shortages of supplies other than gauze were less severe, with shortages of syringes being least severe. But there were still 6% of facilities at district level and another 10% of facilities interviewed that had no supplies. 50% of facilities were short of syringes. The figures for lacking surgical gloves were 28% and 17%, respectively, with 58% suffering from shortages.

Conflicting information was received from Kenya and none at all from Uganda. Kenya did experience shortages of gauze, said to be due to a global shortage of cotton. Africa, including East Africa, produces a lot of cotton. But that is unlikely to have much impact on medical supplies that mainly come from large pharmaceutical multinationals, rather than from non-Western manufacturers.

I can certainly see why UNAIDS would recommend to its employees that they avoid health facilities that are not approved by the UN when working in African countries. But I don’t understand why UNAIDS don’t think that Africans themselves are in any danger. Are Africans not entitled to the same warnings about unsafe healthcare as UN employees?

Tanzania to Pioneer Exclusive Use of Self-Destruct Syringe


Marc Koska’s SafePoint Trust got some well deserved coverage in the English Guardian last Friday. Having spent years researching and building up the skills necessary, he developed a syringe that cannot be reused. Despite UNAIDS’ and WHO’s constant denials, reuse of injecting equipment is very common in poor countries, where there is a high prevalence of blood borne viruses such as HIV, hepatitis and many bacterial infections. Such reuse is also extremely dangerous; in the case of HIV, risk of infection from reused injecting equipment is many times higher than unprotected heterosexual sex.

Exclusive use of this technology for preventive and curative injections will be pioneered in Tanzania. Koska used some secret filming of injecting equipment reuse to persuade the Minister of Health and Social Welfare of the need for such a change in injecting practices. She was convinced. The WHO does, to a limited extent, accept that there is a problem. They say 1.3 million people die from injecting equipment reuse every year. They just don’t bother making it clear to people in high HIV prevalence countries how common these practices are, or how people can avoid being infected.

SafePoint also adds some of the estimated figures for people infected with serious and life-threatening diseases from syringe reuse: an estimated 7 billion of the 17 billion injections administered every year are unsafe; 21 million transmissions of hepatitis B and 2 million of hepatitis C; 20 million medical injections in Africa alone contaminated with HIV; more than half of HIV positive transmissions in children in Europe were a result of contaminated equipment reuse in Romania, alone.

Asking people here in East Africa who work in healthcare about injecting equipment reuse, including those specializing in HIV, generally elicits denial, even hostility. Many people are vaguely aware that HIV can be transmitted through non-sexual routes; they just happen to swallow the HIV industry’s reassurances that almost all transmission is through heterosexual sex. Because they don’t see non-sexual routes as a threat to their health or the health of their families, they pay little or no attention to avoiding the risk.

Koska tries to hammer the point home by citing figures for the difference between the number of injections administered and the number of syringes imported. He finds that “Tanzania has 45 million people and they are importing 40m syringes. With an average of five injections each a year, they need 220m”. As he reminds us, immunization only accounts for about 10% of injections, the other 90% being accounted for by treatment.

Self-destruct or ‘autodisable’ syringes, such as the ones Koska’s company manufactures, are as cheap to produce  as non-autodisable syringes. However, it is slow to change practices where commercial interests are involved. Given UNAIDS’ and WHO’s lack of interest in non-sexual transmission of HIV and other diseases, indeed, their active opposition to warning Africans against such threats, it is not surprising that manufacturers of these unsafe syringes see no reason to make changes.

Let’s hope Koska’s SafePoint Trust program in Tanzania reveals something of the true extent of the problem so that other medium and high HIV prevalence countries can follow suit so that infection rates can be cut, perhaps substantially.

[Watch the five minute video about Koska’s SafePoint campaign and the undercover filming of contaminated syringe being used on a HIV positive man and reused on an infant.]

Make Blood Transfusion Services Safer, then Try to Win Back Public Confidence


The Citizen has an article about Tanzanians being reluctant to donate blood in the Mbeya region, in the South of the country. The article suggests that there is a lack of awareness about the safe blood program that gives rise to this reluctance.  Apparently, some people fear that donating blood will do them some harm.

While people needn’t worry about donating blood making them sick or weak, they might have reason to worry about the safety of the blood transfusion services. There may also be legitimate worries about receiving a transfusion in places where infection control procedures are poor, such as Tanzania. Mbeya is also one of the high HIV prevalence regions, with rates far higher than average.

Shortages of donated blood can lead to avoidable deaths. But it would be wrong to insist that everything is perfectly safe for donors and those receiving transfusions when this may not be the case. Perhaps the World Health Organization, in its great wisdom, will investigate the safety of blood transfusion and other services that may risk transmitting HIV, hepatitis and other blood borne diseases. Otherwise their assurances are useless.

A Tanzanian researcher, Dominic Mosha, carried out a study into the safety of pediatric blood transfusions in two hospitals in the North of Tanzania. He found that only 10% of the blood transfused came from the blood bank. The other 90% came directly from donors, often family members. The blood from direct donors was screened for HIV and syphilis, but it was not screened for hepatitis B and C.

Instead of calling for more people to donate and letting them think they are perfectly safe in doing so, it would be far better to accept that there are some problems and to work with the relevant authorities to resolve these. But lying about the risks when they have not been properly investigated is not going to increase confidence in blood transfusion services or health services in general.

Diabetics May Face Hepatitis B Risk from Glucose Meters


The San Francisco Chronicle has an article about glucose meters for diabetics being reused without cleaning. People with diabetes have been found to face double the risk of being infected with hepatitis B compared to those without diabetes. The Centers for Disease Control recommend vaccinations against hepatitis B and other measures to reduce likelihood of transmission.

Dr Joseph Sonnabend sent me the article, pointing out that this is the situation in industrialized countries, where health services are in far better condition than in developing countries, where rates of hepatitis B and other blood borne viruses can be very high. In such scenarios, it would probably be advisable to test for hepatitis C and HIV also.

Dr Sonnabend points out that diabetes is a complication of some commonly used HIV drugs. But it is also very common in countries where poor diet and other factors lead to high disease burdens. Many people in developing countries who develop diabetes are unlikely to be tested until the condition has reached a critical stage and they are also less likely to receive treatment, because of cost, lack of access to health facilities or a combination of problems.

Apparently outbreaks of hepatitis B have been common among diabetics for many years. Therefore, those in developing countries who do have access to health facilities may face far higher risks from hepatitis B, C, HIV and perhaps other blood borne diseases. It just seems unlikely that infection control procedures in these countries will pick up the thread and deal with it adequately.

UNAIDS and other institutions seem keen to deny the possibility of reuse of contaminated skin piercing instruments in health facilities giving rise to infection with HIV or other diseases. But the only reason people in high HIV prevalence countries are unlikely to face such risks seems to be that many of them are unlikely to be able to afford treatment.